{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:56:40Z","timestamp":1770436600073,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Chao Wang of Pharma Data Associates LLC"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jad.2013.07.023","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T11:47:59Z","timestamp":1376653679000},"page":"854-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)"],"prefix":"10.1016","volume":"151","author":[{"given":"Saeheon","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiun","family":"Pae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanchard Portland","family":"Kimberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Craig Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin A.","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jad.2013.07.023_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-0327(94)90025-6","article-title":"Childhood psychopathology retrospectively assessed among adults with early onset major depression","volume":"31","author":"Alpert","year":"1994","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2013.07.023_bib2","first-page":"4","article-title":"Treatment of patients with eating disorders","volume":"163","year":"2006"},{"key":"10.1016\/j.jad.2013.07.023_bib3","series-title":"Practice guideline for the treatment of patients with major depressive disorder","year":"2010"},{"issue":"2","key":"10.1016\/j.jad.2013.07.023_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4088\/JCP.v64n0216","article-title":"A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder","volume":"64","author":"Amsterdam","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2013.07.023_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.jcp.0000239794.37073.70","article-title":"Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial","volume":"26","author":"Amsterdam","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.jad.2013.07.023_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2005.06.011","article-title":"MAOI efficacy and safety in advanced stage treatment-resistant depression\u2014a retrospective study","volume":"89","author":"Amsterdam","year":"2005","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1016\/j.jad.2013.07.023_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0269881107088441","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines","volume":"22","author":"Anderson","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"8","key":"10.1016\/j.jad.2013.07.023_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/0091270006289852","article-title":"Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6mg\/24h in healthy subjects","volume":"46","author":"Azzaro","year":"2006","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1\u20133","key":"10.1016\/j.jad.2013.07.023_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-0327(02)00081-2","article-title":"Risk factors for depression at 12-month follow-up in adult primary health care patients with major depression: an international prospective study","volume":"76","author":"Barkow","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1016\/j.jad.2013.07.023_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/eat.20369","article-title":"Outcomes of eating disorders: a systematic review of the literature","volume":"40","author":"Berkman","year":"2007","journal-title":"International Journal of Eating Disorders"},{"issue":"1","key":"10.1016\/j.jad.2013.07.023_bib11","first-page":"63","article-title":"Clinical presentation and course of depression in youth: does onset in childhood differ from onset in adolescence?","volume":"43","author":"Birmaher","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2013.07.023_bib12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1176\/appi.ajp.159.11.1869","article-title":"Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients","volume":"159","author":"Bodkin","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2013.07.023_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.10m06314","article-title":"Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study","volume":"73","author":"Ciudad","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2013.07.023_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1176\/ajp.148.10.1353","article-title":"Predictors of relapse into major depressive disorder in a nonclinical population","volume":"148","author":"Coryell","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2013.07.023_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2008.05.023","article-title":"Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder","volume":"113","author":"Fava","year":"2009","journal-title":"Journal of Affective Disorders"},{"issue":"9","key":"10.1016\/j.jad.2013.07.023_bib16","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4088\/JCP.v67n0905","article-title":"Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial","volume":"67","author":"Feiger","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2013.07.023_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1017\/S0033291703008377","article-title":"Socio-economic status, family disruption and residential stability in childhood: relation to onset, recurrence and remission of major depression","volume":"33","author":"Gilman","year":"2003","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.jad.2013.07.023_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.psychres.2005.07.012","article-title":"Treatment of depression with atypical features: a meta-analytic approach","volume":"141","author":"Henkel","year":"2006","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/j.jad.2013.07.023_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.JGP.0000196630.57751.44","article-title":"Depressive symptom deterioration in a large primary care-based elderly cohort","volume":"14","author":"Katon","year":"2006","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jad.2013.07.023_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(99)00020-8","article-title":"Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response","volume":"55","author":"Klein","year":"1999","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.jad.2013.07.023_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0327(02)00429-9","article-title":"Developmental changes in the phenomenology of depression in girls compared to boys from childhood onward","volume":"74","author":"Kovacs","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2013.07.023_bib26","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jad.2009.06.041","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy","volume":"117","author":"Lam","year":"2009","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.jad.2013.07.023_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1037\/0021-843X.98.2.107","article-title":"Probability of relapse after recovery from an episode of depression","volume":"9898","author":"Lewinsohn","year":"1989","journal-title":"Journal of Abnormal Psychology"},{"issue":"5","key":"10.1016\/j.jad.2013.07.023_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1017\/S003329170100407X","article-title":"Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study","volume":"31","author":"Lowe","year":"2001","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.jad.2013.07.023_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.2042-7158.2003.tb02430.x","article-title":"Daily transdermal administration of selegiline to guinea-pigs preferentially inhibits monoamine oxidase activity in brain when compared with intestinal and hepatic tissues","volume":"55","author":"Mawhinney","year":"2003","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"7","key":"10.1016\/j.jad.2013.07.023_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4088\/JCP.v61n0710","article-title":"Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression","volume":"61","author":"McGrath","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2013.07.023_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3928\/0048-5713-20010601-06","article-title":"The use of monoamine oxidase inhibitors for treating atypical depression","volume":"31","author":"Mcgrath","year":"2001","journal-title":"Psychiatric Annals"},{"issue":"9","key":"10.1016\/j.jad.2013.07.023_bib33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1176\/ajp.2006.163.9.1542","article-title":"Predictors of relapse in a prospective study of fluoxetine treatment of major depression","volume":"163","author":"McGrath","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2013.07.023_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jad.2010.10.043","article-title":"Depression and eating disorders: treatment and course","volume":"130","author":"Mischoulon","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.jad.2013.07.023_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1176\/appi.ajp.163.1.95","article-title":"Six months of treatment for depression: outcome and predictors of the course of illness","volume":"163","author":"Mulder","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl. 8","key":"10.1016\/j.jad.2013.07.023_bib36","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression.","volume":"68","author":"Nemeroff","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2013.07.023_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR\u204eD report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1016\/j.jad.2013.07.023_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1192\/bjp.169.4.423","article-title":"Seven year prognosis in depression. Mortality and readmission risk in the Nottingham ECT cohort","volume":"169","author":"O'Leary","year":"1996","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2013.07.023_bib40","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archpsyc.1984.01790190056007","article-title":"Identification of true drug response to antidepressants. Use of pattern analysis","volume":"41","author":"Quitkin","year":"1984","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2013.07.023_bib1001","doi-asserted-by":"crossref","unstructured":"Rush, A.J., Trivedi M.H., et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Pychiatry 163(11) 1905\u20131917.","DOI":"10.1176\/ajp.2006.163.11.1905"},{"issue":"4","key":"10.1016\/j.jad.2013.07.023_bib41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archpsyc.55.4.334","article-title":"Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo","volume":"55","author":"Stewart","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2013.07.023_bib42","series-title":"Texas Medication Algorithm Project Procedural Manual: Major Depressive Disorder Algorithms","author":"Suehs","year":"2009"},{"issue":"8","key":"10.1016\/j.jad.2013.07.023_bib43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4088\/JCP.08m04858blu","article-title":"Prediction of recurrence in recurrent depression: a 5.5-year prospective study","volume":"71","author":"Ten Doesschate","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 8","key":"10.1016\/j.jad.2013.07.023_bib44","first-page":"11","article-title":"Recognition and diagnosis of atypical depression","volume":"68","author":"Thase","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2013.07.023_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4088\/JCP.11096su1c.02","article-title":"The role of monoamine oxidase inhibitors in depression treatment guidelines","volume":"73","author":"Thase","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2013.07.023_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004850-199300840-00008","article-title":"Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression","volume":"8","author":"Tollefson","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"issue":"10","key":"10.1016\/j.jad.2013.07.023_bib47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archpsyc.1992.01820100039008","article-title":"The course of major depression in the offspring of depressed parents. Incidence, recurrence, and recovery","volume":"49","author":"Warner","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2013.07.023_bib48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0006-3223(02)01892-9","article-title":"Transdermal selegiline: targeted effects on monoamine oxidases in the brain","volume":"54","author":"Wecker","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jad.2013.07.023_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-0327(98)00170-0","article-title":"Psychological predictors of single and recurrent major depressive episodes","volume":"54","author":"Wilhelm","year":"1999","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.jad.2013.07.023_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00406-009-0031-3","article-title":"Type of residual symptom and risk of relapse during the continuation\/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine","volume":"260","author":"Yang","year":"2010","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713005922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713005922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:12:17Z","timestamp":1759021937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032713005922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0165032713005922"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2013.07.023","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2013.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}